name: E-MTAB-14952:RSA-PCa-1
characteristics.text: 2025-05-01
characteristics.characteristic: ENA first public
characteristics.text: ERC000011
characteristics.characteristic: ENA-CHECKLIST
characteristics.text: Director, Transcriptomics Wren Laboratories LLC
characteristics.characteristic: INSDC center name
characteristics.text: public
characteristics.characteristic: INSDC status
characteristics.text: ERS23834651
characteristics.characteristic: SRA accession
characteristics.text: E-MTAB-14952:RSA-PCa-1
characteristics.characteristic: Submitter Id
characteristics.text: ArrayExpress
characteristics.characteristic: broker name
characteristics.text: not collected
characteristics.characteristic: collection date
characteristics.text: human
characteristics.characteristic: common name
characteristics.text: Protocols: Whole blood was collected by prospect study in USA and RSA. Trizol method used to isolate total RNA from whole blood 50 ng of total RNA using oligo-dT beads and fragmented by incubation at 94C in the presence of Mg2+ (Kapa mRNA Hyper Prep).
characteristics.characteristic: description
characteristics.text: prostate cancer
characteristics.characteristic: disease
characteristics.text: not collected
characteristics.characteristic: geographic location (country and/or sea)
characteristics.text: not applicable
characteristics.characteristic: isolate
characteristics.text: Homo sapiens
characteristics.characteristic: organism
characteristics.text: Homo sapiens
characteristics.characteristic: organism
characteristics.text: blood
characteristics.characteristic: organism part
characteristics.text: Homo sapiens
characteristics.characteristic: scientific_name
characteristics.text: male
characteristics.characteristic: sex
characteristics.text: RSA-PCa-1
characteristics.characteristic: title